← Back to catalogue

Anti-β2-GP1 IgG CLIA Microparticles

EUDAMED

Class C (EU MDR)

Ref CMQ3108Model AutoLumo analyzer

by Autobio Diagnostics Co., Ltd.

Identity

Trade Name
Anti-β2-GP1 IgG CLIA Microparticles EUDAMED
Model / Reference
AutoLumo analyzer EUDAMED
CMQ3108 EUDAMED

Identifiers

Primary DI / UDI-DI
06942359514224 EUDAMED
Basic UDI-DI
697015090000323HB EUDAMED
EMDN Code
W0102100503 ANTI-B2-GLYCOPROTEIN I ANTIBODIES EUDAMED

Classification

Device Class
Class C EUDAMED
Market of Registration
Italy EUDAMED

Clinical & Handling

Sterile

No

EUDAMED

Human Tissues

Yes

EUDAMED

Animal Tissues

Yes

EUDAMED

Microbial Substances

No

EUDAMED

Reagent

Yes

EUDAMED

Self Testing

No

EUDAMED

Near-Patient Testing

No

EUDAMED

Professional Testing

Yes

EUDAMED

Companion Diagnostics

No

EUDAMED

Surgical Instrument

No

EUDAMED

New Device

No

EUDAMED

Anti-β2-GP1 IgG CLIA Microparticles by Autobio Diagnostics Co., Ltd. — Class C — IVDR — listed in EUDAMED — regulatory data on deviCERTS

Authorization Coverage (European Union — 27 member states)

Regulatory Authorizations

European Union Active

CE/IVDR

Is this your device? Claim it to add documentation and request validation.

Manufacturer

EUDAMED SRN
CN-MF-000003348
Authorised Representative
QbD RepS BV BE-AR-000000040

Sources (1)

  • EUDAMED f4b22b16-75f1-404a-80cc-1730bef1cc35 61 fields · synced Jun 19, 2026